These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 8571103)
21. Phylogenetic analysis of clinical mumps virus isolates from vaccinated and non-vaccinated patients with mumps during an outbreak, Switzerland 1998-2000. Utz S; Richard JL; Capaul S; Matter HC; Hrisoho MG; Mühlemann K J Med Virol; 2004 May; 73(1):91-6. PubMed ID: 15042654 [TBL] [Abstract][Full Text] [Related]
22. A combination measles, mumps, rubella, and varicella vaccine (ProQuad) given to 4- to 6-year-old healthy children vaccinated previously with M-M-RII and Varivax. Reisinger KS; Brown ML; Xu J; Sullivan BJ; Marshall GS; Nauert B; Matson DO; Silas PE; Schödel F; Gress JO; Kuter BJ; Pediatrics; 2006 Feb; 117(2):265-72. PubMed ID: 16452343 [TBL] [Abstract][Full Text] [Related]
23. Assessment of one-dose mumps-containing vaccine effectiveness on wild-type genotype F mumps viruses circulating in mainland China. Cui A; Zhu Z; Mao N; Si Y; Ma Y; Hu Y; Deng X; Wang L; Zeng L; Zhang Y; Xu W Vaccine; 2018 Sep; 36(38):5725-5731. PubMed ID: 30122648 [TBL] [Abstract][Full Text] [Related]
24. Mumps outbreaks in vaccinated populations: are available mumps vaccines effective enough to prevent outbreaks? Dayan GH; Rubin S Clin Infect Dis; 2008 Dec; 47(11):1458-67. PubMed ID: 18959494 [TBL] [Abstract][Full Text] [Related]
25. [An intranasal method of revaccination against mumps]. Krasnova VP; Iuminova NV; Liashenko VA Vopr Virusol; 1994; 39(1):24-6. PubMed ID: 8160444 [TBL] [Abstract][Full Text] [Related]
26. Rubella, rubeola, and mumps in pregnant women: susceptibilities and strategies for testing and vaccinating. Haas DM; Flowers CA; Congdon CL Obstet Gynecol; 2005 Aug; 106(2):295-300. PubMed ID: 16055578 [TBL] [Abstract][Full Text] [Related]
27. [Virus strain specific serum neutralizing antibodies in children and adolescents immunized with a Russian mumps vaccine]. Otrashevskaia EV; Krasil'nikov IV; Ignat'ev GM Vopr Virusol; 2010; 55(6):15-9. PubMed ID: 21381334 [TBL] [Abstract][Full Text] [Related]
28. [Community effectiveness of vaccines against infectious parotiditis (mumps). Report of cases]. Limón Mora J; Molina López T; Domínguez Camacho JC Rev Esp Salud Publica; 1999; 73(4):455-64. PubMed ID: 10575934 [TBL] [Abstract][Full Text] [Related]
30. Immunogenicity and safety of measles-mumps-rubella-varicella (MMRV) vaccine followed by one dose of varicella vaccine in children aged 15 months-2 years or 2-6 years primed with measles-mumps-rubella (MMR) vaccine. Gillet Y; Steri GC; Behre U; Arsène JP; Lanse X; Helm K; Esposito S; Meister N; Desole MG; Douha M; Willems P Vaccine; 2009 Jan; 27(3):446-53. PubMed ID: 19007835 [TBL] [Abstract][Full Text] [Related]
31. Mumps outbreaks in Canada and the United States: time for new thinking on mumps vaccines. Peltola H; Kulkarni PS; Kapre SV; Paunio M; Jadhav SS; Dhere RM Clin Infect Dis; 2007 Aug; 45(4):459-66. PubMed ID: 17638194 [TBL] [Abstract][Full Text] [Related]
32. Humoral immune response after post-chemotherapy booster diphtheria-tetanus-pertussis vaccine in pediatric oncology patients. Cheng FW; Leung TF; Chan PK; Lee V; Shing MK; Chik KW; Yuen PM; Li CK Pediatr Blood Cancer; 2009 Feb; 52(2):248-53. PubMed ID: 18937325 [TBL] [Abstract][Full Text] [Related]
34. Immunogenicity and safety of a combined DTaP-IPV vaccine compared with separate DTaP and IPV vaccines when administered as pre-school booster doses with a second dose of MMR vaccine to healthy children aged 4-6 years. Black S; Friedland LR; Schuind A; Howe B; Vaccine; 2006 Aug; 24(35-36):6163-71. PubMed ID: 16759769 [TBL] [Abstract][Full Text] [Related]
35. The immunizing effect and reactogenicity of two live attenuated mumps virus vaccines in Swedish schoolchildren. Christenson B; Heller L; Böttiger M J Biol Stand; 1983 Oct; 11(4):323-31. PubMed ID: 6643511 [TBL] [Abstract][Full Text] [Related]
36. [Epidemic parotitis in Italy: results of a 1st vaccination trial]. Midulla M; Tamburello O; Balducci L; Assensio AM; Finocchiaro M; Chicca A; Sabatino G Ann Sclavo; 1977; 19(2):177-86. PubMed ID: 603264 [TBL] [Abstract][Full Text] [Related]
37. Persistent humoral immune defect in highly active antiretroviral therapy-treated children with HIV-1 infection: loss of specific antibodies against attenuated vaccine strains and natural viral infection. Bekker V; Scherpbier H; Pajkrt D; Jurriaans S; Zaaijer H; Kuijpers TW Pediatrics; 2006 Aug; 118(2):e315-22. PubMed ID: 16847077 [TBL] [Abstract][Full Text] [Related]
38. Effectiveness of previous mumps vaccination during a summer camp outbreak. Schaffzin JK; Pollock L; Schulte C; Henry K; Dayan G; Blog D; Smith P Pediatrics; 2007 Oct; 120(4):e862-8. PubMed ID: 17908742 [TBL] [Abstract][Full Text] [Related]
39. Assessment of humoral immunity to poliomyelitis, tetanus, hepatitis B, measles, rubella, and mumps in children after chemotherapy. Zignol M; Peracchi M; Tridello G; Pillon M; Fregonese F; D'Elia R; Zanesco L; Cesaro S Cancer; 2004 Aug; 101(3):635-41. PubMed ID: 15274078 [TBL] [Abstract][Full Text] [Related]